Home » Topics » Immune, BioWorld Science

Immune, BioWorld Science
RSS

Vertex acquires ICE patent portfolio from Sanofi

Aug. 5, 1997

Novel immunomodulating agents from Gruenenthal

July 31, 1997

Cypros licenses patents for CPC-111 in organ transplant

July 30, 1997

New emulsion formulation of tacrolimus provides local immunosuppression

July 30, 1997

SangStat Medical reports encouraging phase III results with Thymoglobulin

July 29, 1997

DynaGen expands ImmuDyn development

July 24, 1997

Mycophenolic acid derivatives with immunosuppressive activity claimed

July 17, 1997

Intranasal flu vaccine effective and safe in children

July 16, 1997

Vical and Pasteur Merieux Connaught initiate phase I malaria trial

July 14, 1997

Virus Research Institute's rotavirus vaccine enters phase II

July 11, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...